| |
|
|
|
Cancer Genetics- Inc.  
|
|
0.9001 -0.1 (-0.1%) |
06-22 16:00 |
|
Open: |
0.9885 |
Pre close: |
1 |
Target:
|
1.23 
|
|
High: |
0.9885 |
Low: |
0.9001 |
Resistance:
|
1.06
1.16
|
|
Volume: |
107,294 |
Market Cap: |
25M |
Support:
|
0.89
0.74
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.98
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
1.01 |
Signal(12,26,9): |
-0.00 |
|
MA(100): |
1.34 |
Stochastic Oscillator |
%K(14,3):
|
18.18 |
|
MA(250): |
2.28 |
%D(3): |
27.27 |
|
Average Volume(K) |
3-Month: |
78899
|
52-Week |
High:
|
4.25 |
|
10-Days: |
10659 |
Low: |
0.82 |
|
RSI |
RSI(14):
|
38.30 |
Change(%): |
-77.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.830 |
Return on Equity (ttm) |
-71.2 |
Shares Out. (M) |
27.75 |
|
EPS Est. Current Year |
-0.860 |
Return on Assets (ttm) |
-32.6 |
Shares Float (M) |
24.48 |
|
EPS Est. Next Year |
-0.260 |
PEG Ratio |
-0.04 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.100 |
Qtrly Rev. Growth |
4.1 |
% Held by Institutions |
12.70 |
|
Forward EPS |
-0.290 |
Gross Profit (p.s.) |
0.217 |
Shares Short (K) |
566 |
|
Book Value (p.s.) |
1.480 |
EBITDA (p.s.) |
-0.063 |
P/E |
-1.08 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.61 |
|
Profit Margin |
-52.28 |
Operating Cash Flow
(M) |
-13.56 |
P/S |
17714734.00 |
|
Operating Margin |
-63.95 |
Levered Free Cash Flow
(M) |
-8.46 |
P/CF |
-1.84 |
|
|
|
|
|
|
